The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 16, 2022
Filed:
Feb. 11, 2019
Applicant:
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Inventors:
Mark W. Embrey, Harleysville, PA (US);
Timothy John Hartingh, Richlandtown, PA (US);
Marc Labroli, Moorestown, NJ (US);
Izzat T. Raheem, Doylestown, PA (US);
Assignee:
Merck, Sharp & Dohme LLC, Rahway, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/53 (2006.01); A61K 31/427 (2006.01); A61K 31/4418 (2006.01); A61K 31/505 (2006.01); A61K 31/513 (2006.01); A61K 31/52 (2006.01); A61K 31/5365 (2006.01); A61K 31/635 (2006.01); A61K 31/675 (2006.01); A61K 31/7068 (2006.01); C07D 471/18 (2006.01); C07D 498/18 (2006.01);
U.S. Cl.
CPC ...
A61K 31/53 (2013.01); A61K 31/427 (2013.01); A61K 31/4418 (2013.01); A61K 31/505 (2013.01); A61K 31/513 (2013.01); A61K 31/52 (2013.01); A61K 31/5365 (2013.01); A61K 31/635 (2013.01); A61K 31/675 (2013.01); A61K 31/7068 (2013.01); C07D 471/18 (2013.01); C07D 498/18 (2013.01);
Abstract
The present invention relates to Tricyclic Heterocycle Compounds of Formula (I): and pharmaceutically acceptable salts or prodrug thereof, wherein X, Y, Z, Rand n are as defined herein. The present invention also relates to compositions comprising at least one Tricyclic Heterocycle Compound, and methods of using the Tricyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.